Research suggests that L-carnitine supplementation may produce modest benefits for weight management, particularly in individuals who are overweight or obese. A 2020 meta-analysis pooling data from 43 randomized controlled trials found statistically significant but small reductions in body weight, BMI, and fat mass, while a 2026 systematic review and network meta-analysis found L-carnitine showed the most consistent benefits across weight and metabolic outcomes compared to several other nutraceuticals, and a 2023 randomized controlled trial suggested that combining L-carnitine with a synbiotic may amplify these effects beyond what L-carnitine alone produces. Studies indicate that effects appear more pronounced when supplementation is paired with other lifestyle changes such as diet or exercise, and that simply increasing the dose does not reliably increase results, pointing to a more complex dose-response relationship. That said, a narrative review examining the broader weight-management supplement landscape characterized the overall evidence base as not yet consistent or robust enough to draw firm conclusions, and several studies in the linked set address unrelated topics such as rare metabolic disorders, computational modeling, and animal physiology, which do not contribute meaningfully to the human weight-loss question and underscore the importance of evaluating evidence specific to the population and outcome of interest.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Beneficial effects of l-carnitine supplementation for weight management in ov... | Meta-analysis | 2020 | Supports | 100 |
| Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthr... | RCT | 2023 | Supports | 95 |
| Nutraceuticals for the management of weight and inflammation-related complica... | Systematic review | 2026 | Supports | 90 |
| Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clini... | Review | 2026 | Mixed | 85 |
| A multiomic network approach uncovers disease modifying mechanisms of inborn ... | Other | 2025 | Neutral | 85 |
| Dynamic whole-body models for infant metabolism | Other | 2024 | Neutral | 80 |
| Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan. | Other | 2013 | Mixed | 80 |
| Biological landscape of acute illness in children in sub-Saharan Africa and S... | Other | 2025 | Neutral | 75 |
| Cats in Positive Energy Balance Have Lower Rates of Adipose Gain When Fed Die... | Other | 2016 | Supports | 75 |
| Targeting immunometabolic pathways with AZD1656 alleviates inflammation and m... | Other | 2025 | Neutral | 70 |
| Mechanistic basis for protection against fatty liver disease by <i>CIDEB</i> ... | Other | 2025 | Neutral | 65 |
| Personalised metabolic whole-body models for newborns and infants predict gro... | Other | 2023 | Neutral | 60 |
| Upregulation of steroidogenesis is associated with coma in human cerebral mal... | Other | 2023 | Neutral | 55 |
| Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodys... | Other | 2023 | Neutral | 50 |
| Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory protei... | Other | 2023 | Neutral | 45 |